Previous Article | Next Article 
Journal of Virology, March 1999, p. 1828-1834, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Requirements for Efficient Production and
Transduction of Human Immunodeficiency Virus Type 1-Based
Vectors
Mehdi
Gasmi,
Jacqueline
Glynn,
Ming-Jie
Jin,
Douglas J.
Jolly,
Jiing-Kuan
Yee, and
Shin-Tai
Chen*
Center for Gene Therapy, Chiron Technologies,
San Diego, California 92121
Received 28 August 1998/Accepted 12 November 1998
A number of human immunodeficiency type 1 (HIV-1)-based vectors
have recently been shown to transduce nondividing cells in vivo as well
as in vitro. However, if these vectors are to be considered for
eventual clinical use, a major consideration is to reduce the
probability of unintended generation of replication-competent virus.
This can be achieved by eliminating viral genetic elements involved in
the generation of replication-competent virus without impairing vector
production. We have designed a system to transiently produce
HIV-1-based vectors by using expression plasmids encoding Gag, Pol, and
Tat of HIV-1 under the control of the cytomegalovirus immediate-early
promoter. Our data show that the best vector yield is achieved in the
presence of the Rev/Rev-responsive element (RRE) system. However, the
constitutive transport element of Mason-Pfizer monkey virus can
substitute for RRE and Rev at least to some extent, whereas the
posttranscriptional regulatory element of human hepatitis B virus
appeared to be inefficient. In addition, we show that high-titer virus
preparations can be obtained in the presence of sodium butyrate, which
activates the expression of both the packaging construct and the vector
genome. Finally, our results suggest that efficient infectivity of
vectors defective in the accessory proteins Vif, Vpr, Vpu, and Nef
depends on the nature of the target cells.
*
Corresponding author. Present address: Jerry L. Pettis
VAMC and Loma Linda University, Mineral Metabolism (151), 11201 Benton St., Loma Linda, CA 92357. Phone: (909) 422-3101. Fax: (909) 796-1680. E-mail: STChen{at}netscape.net.
Journal of Virology, March 1999, p. 1828-1834, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zachos, N. C., Li, X., Kovbasnjuk, O., Hogema, B., Sarker, R., Lee, L. J., Li, M., de Jonge, H., Donowitz, M.
(2009). NHERF3 (PDZK1) Contributes to Basal and Calcium Inhibition of NHE3 Activity in Caco-2BBe Cells. J. Biol. Chem.
284: 23708-23718
[Abstract]
[Full Text]
-
Malyukova, I., Murray, K. F., Zhu, C., Boedeker, E., Kane, A., Patterson, K., Peterson, J. R., Donowitz, M., Kovbasnjuk, O.
(2009). Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis. Am. J. Physiol. Gastrointest. Liver Physiol.
296: G78-G92
[Abstract]
[Full Text]
-
Unwalla, H. J., Li, H.-T., Bahner, I., Li, M.-J., Kohn, D., Rossi, J. J.
(2006). Novel Pol II Fusion Promoter Directs Human Immunodeficiency Virus Type 1-Inducible Coexpression of a Short Hairpin RNA and Protein. J. Virol.
80: 1863-1873
[Abstract]
[Full Text]
-
Amaar, Y. G., Thompson, G. R., Linkhart, T. A., Chen, S.-T., Baylink, D. J., Mohan, S.
(2002). Insulin-like Growth Factor-binding Protein 5 (IGFBP-5) Interacts with a Four and a Half LIM Protein 2 (FHL2). J. Biol. Chem.
277: 12053-12060
[Abstract]
[Full Text]
-
Kowolik, C. M., Hu, J., Yee, J.-K.
(2001). Locus Control Region of the Human CD2 Gene in a Lentivirus Vector Confers Position-Independent Transgene Expression. J. Virol.
75: 4641-4648
[Abstract]
[Full Text]
-
Mautino, M. R., Keiser, N., Morgan, R. A.
(2001). Inhibition of Human Immunodeficiency Virus Type 1 (HIV-1) Replication by HIV-1-Based Lentivirus Vectors Expressing Transdominant Rev. J. Virol.
75: 3590-3599
[Abstract]
[Full Text]
-
Gruber, A., Kan-Mitchell, J., Kuhen, K. L., Mukai, T., Wong-Staal, F.
(2000). Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro. Blood
96: 1327-1333
[Abstract]
[Full Text]
-
Srinivasakumar, N., Schuening, F.
(2000). Novel Tat-Encoding Bicistronic Human Immunodeficiency Virus Type 1-Based Gene Transfer Vectors for High-Level Transgene Expression. J. Virol.
74: 6659-6668
[Abstract]
[Full Text]
-
Nishizawa, M., Kamata, M., Katsumata, R., Aida, Y.
(2000). A Carboxy-Terminally Truncated Form of the Human Immunodeficiency Virus Type 1 Vpr Protein Induces Apoptosis via G1 Cell Cycle Arrest. J. Virol.
74: 6058-6067
[Abstract]
[Full Text]
-
Kotsopoulou, E., Kim, V. N., Kingsman, A. J., Kingsman, S. M., Mitrophanous, K. A.
(2000). A Rev-Independent Human Immunodeficiency Virus Type 1 (HIV-1)-Based Vector That Exploits a Codon-Optimized HIV-1 gag-pol Gene. J. Virol.
74: 4839-4852
[Abstract]
[Full Text]
-
Wodrich, H., Schambach, A., Krausslich, H.-G.
(2000). Multiple copies of the Mason-Pfizer monkey virus constitutive RNA transport element lead to enhanced HIV-1 Gag expression in a context-dependent manner. Nucleic Acids Res
28: 901-910
[Abstract]
[Full Text]
-
Srinivasakumar, N., Schuening, F. G.
(1999). A Lentivirus Packaging System Based on Alternative RNA Transport Mechanisms To Express Helper and Gene Transfer Vector RNAs and Its Use To Study the Requirement of Accessory Proteins for Particle Formation and Gene Delivery. J. Virol.
73: 9589-9598
[Abstract]
[Full Text]
-
DePolo, N. J., Harkleroad, C. E., Bodner, M., Watt, A. T., Anderson, C. G., Greengard, J. S., Murthy, K. K., Dubensky, T. W. Jr., Jolly, D. J.
(1999). The Resistance of Retroviral Vectors Produced from Human Cells to Serum Inactivation In Vivo and In Vitro Is Primate Species Dependent. J. Virol.
73: 6708-6714
[Abstract]
[Full Text]